Dosage Charts Calculator Blends & Stacks Learn Blog Peptides
Open Calculator
Blog  ›  Ovagen vs Prostamax: Simple Research Dosing Comparison

Ovagen vs Prostamax: Simple Research Dosing Comparison

Jun 11, 2026 4 min Bioregulator
TL;DR
Ovagen is a high-purity FSH preparation studied in animal reproductive research, while Prostamax is a short synthetic peptide explored for effects on chromatin activity in aging cells. Their research dosing methods, species contexts, and scientific goals are completely different. Reading about both is easier when you know exactly what each one is.

Two Compounds, Two Totally Different Stories

Sometimes two products share shelf space in research catalogs and people assume they must be related. Ovagen and Prostamax are a great example of that mix-up waiting to happen. They sound similar. They are not similar. Let's fix that.

What Is Ovagen?

Ovagen is a purified follicle-stimulating hormone (FSH) preparation. FSH is a hormone that tells ovaries to develop follicles — the tiny fluid-filled sacs that hold eggs. What makes Ovagen stand out among FSH products is its extremely high FSH-to-LH ratio. One lab measured that ratio at roughly 1,090 to 1 — far higher than competing products like Folligon, which sat at just 5 to 1.[1] In plain terms, Ovagen is almost pure FSH with barely any LH mixed in.

Researchers have used Ovagen in superovulation studies — that means triggering animals to release many eggs at once, useful for embryo collection programs. Studies in goats, sheep, and cattle have all tested it.[4][5][6]

How Is Ovagen Dosed in Research?

Research protocols vary by species, but a few patterns show up consistently:

  • Multiple injections: A common goat protocol used eight separate injections of Ovagen spread over several days.[3]
  • Single injection with PMSG: Researchers also tested single Ovagen injections combined with low doses of another hormone (PMSG) to simplify the protocol.[3]
  • Continuous infusion in rats: In rat studies, Ovagen had to be given by continuous infusion — not simple injection — to produce results. Infusion rates ranged from 30 to 1,000 micrograms per day.[1]
  • Comparable outcomes to competitors: In goats, Ovagen produced a mean of 16.2 corpora lutea and 12.6 recovered embryos per animal — statistically similar to Folltropin.[4]

Want the full breakdown of reported research figures? Check the Ovagen dosing chart and use the calculator to explore scaled values.

What Is Prostamax?

Prostamax is a completely different animal — literally and figuratively. It is a short synthetic peptide, meaning it is a tiny chain of amino acids built in a lab. It belongs to a family of bioregulatory peptides studied primarily in the context of aging biology.

In one key study, researchers looked at what Prostamax and four similar peptides did to the chromosomes of white blood cells taken from people aged 75 to 88 years old.[2] The focus was on chromatin — the tightly packed material that DNA wraps around inside a cell's nucleus. As we age, some genes get locked away inside condensed chromatin and stop working properly. The question was: could these short peptides unlock any of that?

The answer, at least in that lab setting, was yes. Prostamax was among the peptides that activated ribosome genes and caused decondensation of tightly packed chromatin regions, including pericentromeric structural chromatin on chromosome 1.[2] In plain terms: it seemed to loosen up some of the chromosome regions that had been shut down with age.

How Is Prostamax Dosed in Research?

Prostamax research sits firmly in the cellular and gerontology space, not veterinary reproductive medicine. Dosing in the chromatin study was applied directly to isolated leukocytes (white blood cells) in a laboratory setting — not a live-animal injection protocol.[2] This is an important distinction. It means the dosing context is entirely different from Ovagen's field-based injection schedules.

For the full reported figures, visit the Prostamax dosing chart.

Quick Side-by-Side Comparison

  • Type: Ovagen = purified FSH hormone protein | Prostamax = short synthetic peptide
  • Primary research area: Ovagen = animal reproductive medicine | Prostamax = aging biology and chromatin activity
  • Species studied: Ovagen = goats, sheep, cattle, rats[1][3][4][5][6] | Prostamax = human leukocytes (elderly donors)[2]
  • Dosing format in studies: Ovagen = multi-injection or infusion protocols | Prostamax = cell-culture application
  • Key measured outcome: Ovagen = ovulation rate, embryo count | Prostamax = chromatin decondensation, gene activation

How to Choose What to Read About

The choice is really about your research interest, not a head-to-head competition. If you are reading about reproductive biology, superovulation, or embryo transfer in livestock, Ovagen is the relevant compound. If you are reading about peptide bioregulation, cellular aging, or chromatin biology, Prostamax is the paper trail to follow.

Either way, start with the dosing charts and run the numbers through the calculator to get a clearer picture of what the published protocols actually look like scaled out.

Sources

  1. Oocyte production and ovarian steroid concentrations of immature rats in response to some commercial gonadotrophin preparations. — Reproduction, fertility, and development, 1990. PMID 2128901.
  2. Effects of short peptides on lymphocyte chromatin in senile subjects. — Bulletin of experimental biology and medicine, 2004. PMID 15085253.
  3. Use of single or multiple injections of FSH in embryo collection programmes in goats. — Reproduction, fertility, and development, 1993. PMID 8234893.
  4. Superovulation and embryo recovery in goats treated with Ovagen and Folltropin. — New Zealand veterinary journal, 1989. PMID 16031503.
  5. Superovulatory response of dairy cattle (Bos taurus ) in a tropical environment. — Theriogenology, 1997. PMID 16728100.
  6. Effects of FSH commercial preparation and follicular status on follicular growth and superovulatory response in Spanish Merino ewes. — Theriogenology, 2000. PMID 11131324.
See the dosage chart — Ovagen
A liver/GI peptide bioregulator studied for regeneration.
Ovagen

FAQ

Is Ovagen the same as regular FSH?
Ovagen is a commercial FSH preparation, but it is notable for having an exceptionally high FSH-to-LH ratio — measured at around 1,090 to 1 in one study, compared to just 5 to 1 for some competitors.[1] That near-pure FSH profile is what makes it distinct in superovulation research protocols used in goats, sheep, and cattle.
What does Prostamax actually do to cells in research?
In a laboratory study of elderly donors aged 75–88, Prostamax was shown to activate ribosome genes and cause decondensation of tightly packed chromatin in white blood cells.[2] Essentially, it appeared to loosen chromosome regions that had become overly condensed with age, potentially re-activating genes that aging had silenced.
Why did Ovagen require continuous infusion in rat studies?
Unlike Folligon, which worked via simple injection in rats, Ovagen's very high FSH purity and low LH content meant a single injection did not produce oocytes in immature rats.[1] Continuous infusion — delivering the compound steadily over time — was needed to mimic the sustained hormonal signal required to stimulate follicle development and ovulation.
Can Ovagen and Prostamax research be directly compared?
Not really — they study completely different biological systems. Ovagen research focuses on ovarian stimulation and embryo production in livestock species.[4][5] Prostamax research focuses on peptide effects on aging chromosomes in human cells.[2] The compounds serve different scientific questions and are not tested against each other in any published literature.
For research and educational use only. Not medical advice.